TY  - BOOK
AU  - Sameer Melinkeri
AU  - Hasmukh Jain
AU  - Atharva Karulkar
AU  - Devanshi Kalra
TI  - Talicabtagene autoleucel for relapsed or refractory B-cell malignancies: results from an open-label, multicentre, phase 1/2 study
PY  - 2025///
PB  - Lancet Haematol
KW  - Hematology
N1  - DOI: 10.1016/S2352-3026(24)00377-6
UR  - https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S2352302624003776?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2352302624003776%3Fshowall%3Dtrue&referrer=https:%2F%2Fpubmed.ncbi.nlm.nih.gov%2F
ER  -